[Research Report] The T cell therapy market size was valued at US$ 2,754.0 million in 2022 and is expected to reach US$ 9,035.01 million by 2030. It is estimated to register a CAGR of 1… Read More

AI boosts genome enhancing  Labiotech.eu ChatGPT-like AI creates new bacteria-killing proteins  Freethink ProGen AI simply efficiently imitated human evolution  … Read More

The following content is created on behalf of an advertiser. It is not written by our editorial team, and does not necessarily reflect our opinions. For more information, read more h… Read More

Roche and its subsidiary TIB Molbiol have developed a COVID-19 test for researchers that detects and differentiates the latest sub-variant of interest BA.2.75.  The test specifically t… Read More

Badanie fazy trzeciej nowego leku, który leczy nieregularne bicie serca w ciągu zaledwie 30 minut zostało zakończone i wykazało obiecujące wyniki. Lek znan… Read More

LT, 08/08/2022 Por Jim Cornall A Epigenic Therapeutics Co., Ltd., uma empresa chinesa de edição de genes de biotecnologia, garantiu US$ 20 milhões em financiam… Read More

Bacteria pigments may not be a welcome topic for some of us in light of the virus that has ruled the world since early 2020. Our lives, as we knew it, have changed and continues to change to… Read More

kalhh / Pixabay Pfizer to help manufacture Gilead’s remdesivir for COVID-19. Pfizer Inc. (NYC) on Friday said it inked a multiyear agreement to make COVID-19 treatment remdesivir for d… Read More

3dman_eu / Pixabay Quarrel flares up between White House and the CDC over reopening guidelines. The Centers for Disease Control and Prevention has repeatedly found its suggestions for fighti… Read More

felixioncool / Pixabay The News: Germany’s BioNTech raises eye-popping €290M ($325M) in Series B round to fund personalized mRNA cancer vaccines, eschewing IPO for now. Just where… Read More

qimono / Pixabay The News: Momentum Biosciences Ltd. (Cardiff UK) aims to pare back the unnecessary use of antimicrobial drugs in hospitals. To do this, it is developing molecular diagnostic… Read More

cocoparisienne / Pixabay The News: TopiVert Pharma Ltd., a clinical-stage biotechnology company developing narrow spectrum kinase inhibitors (NSKIs) for chronic inflammatory gastrointestinal… Read More

Recently I found myself frequently deleting unwanted e-mails and unsubscribing from various newsletters. However, there were some where I paused when the Unsubscribe button came up and reali… Read More